Pharmala Biotech Holdings Inc. (CSE: MDMA)
Canada
· Delayed Price · Currency is CAD 0.255
-0.015 (-5.56%)
Jan 21, 2025, 11:10 AM EST
Pharmala Biotech Holdings Company Description
Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.
Pharmala Biotech Holdings Inc.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Nicholas Kadysh |
Contact Details
Address: 1055 West Georgia Street Vancouver, British Columbia V6E 4N7 Canada | |
| Website | pharmala.ca |
Stock Details
| Ticker Symbol | MDMA |
| Exchange | Canadian Securities Exchange |
| Reporting Currency | CAD |
| ISIN Number | CA71719L1067 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Nicholas Kadysh | Director, President and Chief Executive Officer |
| Carmelo Marrelli ACIS, B.Comm., C.A., CGA, CPA | Chief Financial Officer and Corporate Secretary |
| Dr. Shane Morris Ph.D. | Chief Operating Officer |
| David Purcell | Director of Sales |